CSBR (Champions Oncology) Dividends per Share: $0.00 (TTM As of Jan. 2026)


CSBR Champions Oncology Inc CSBR
61 GF Score
Price $5.88
GF Value $6.65
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Champions Oncology Dividends per Share?

Champions Oncology CSBR +0.51% 61 Dividends per Share is $0.00 as of Jan. 2026. GuruFocus rates CSBR with a GF Score™ of 61/100 and a GF Value™ of $6.65 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Champions Oncology's dividends per share for the three months ended in Jan. 2026 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00. Its Dividend Payout Ratio for the three months ended in Jan. 2026 was 0.00. As of today, Champions Oncology's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Champions Oncology  (NAS:CSBR) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Champions Oncology's Dividend Payout Ratio for the quarter that ended in Jan. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jan. 2026 )/ EPS without NRI (Q: Jan. 2026 )
=0/ -0.016
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Champions Oncology Dividends per Share Related Terms

Champions Oncology Dividends per Share Historical Data

* Premium members only.

The historical data trend for Champions Oncology's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Champions Oncology Dividends per Share Chart

Champions Oncology Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Champions Oncology Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CSBR vs SEER, RLYB, FBIO: Dividends per Share Comparison

For the Biotechnology subindustry, Champions Oncology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Champions Oncology Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Champions Oncology's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Champions Oncology's Dividend Yield % falls into.


CSBR
61GF Score
Champions Oncology Inc CSBR
Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Champions Oncology Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →
What does a Dividends per Share of $0.00 mean?
Champions Oncology (CSBR) has a Dividends per Share of $0.00 as of Jan. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Champions Oncology and its competitors.
Is Champions Oncology's Dividends per Share too high?
Champions Oncology's current Dividends per Share is $0.00. Overall, Champions Oncology has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Champions Oncology's Dividends per Share compare to SEER and RLYB?
Champions Oncology's Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Biotechnology company?
A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Champions Oncology and its competitors. Champions Oncology's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Champions Oncology stock overvalued right now?
Based on GuruFocus' analysis, Champions Oncology (CSBR) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.65, compared to a current price of $5.88 — trading 11.6% below its estimated fair value. The current Dividends per Share is $0.00. Champions Oncology's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Champions Oncology (CSBR), the current Dividends per Share is $0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Champions Oncology (CSBR) Overvalued in 2026?

Based on GuruFocus' analysis, Champions Oncology stock appears to be undervalued. The current stock price of $5.88 is trading 11.6% below its estimated GF Value™ of $6.65. GuruFocus considers Champions Oncology to be Modestly Undervalued.

Key valuation signals for CSBR:

  • Dividends per Share: $0.00
  • GF Value™: $6.65 vs. price of $5.88 (11.6% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the CSBR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Champions Oncology Business Description

Address One University Plaza, Suite 307, Hackensack, NJ, USA, 07601
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
61GF Score

Get the complete analysis for CSBR

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.88
Price
$6.65
GF Value